BDNF and myeloid sarcoma: Apart from the documented elevation of inflammatory markers in MS, this disease is also correlated with a prominent decline in the neurotrophic factor BDNF in serum of MS patients [34] and EAE animal models [41, 42], facts that support the current findings.